Rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) are the mainstay of biomarkers for arthritis, with ACPA exhibiting a similar sensitivity but better predictability of the disease course than RF [9,10]. This evidence concerns the gene PRTN3 and arthritic joint disease.